title: Thromboembolism and anticoagulation management in the preterm infant.
abstract: The incidence of preterm thromboembolism has been increasing due to advances in diagnostic imaging which allow better detection of thrombi in sick preterm infants. At the same time, improvement in neonatal intensive care unit supportive care has increased the number of surviving and living preterm infants with thromboembolic risk factors. Disruption in the fine balance of hemostasis with potential risk factors, specifically septicemia and indwelling catheters, increase the occurrence of thromboembolic events. Treatment strategies in preterm infants are challenging due to limited data.
authors.affiliation: Pediatric Hemato-Oncology, Department of Pediatrics, University of Malaya, Kuala Lumpur, Malaysia.
authors.forename: Revathi
authors.initials: R
authors.lastname: Rajagopal
authors.affiliation: Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
authors.forename: Fook-Choe
authors.initials: FC
authors.lastname: Cheah
authors.affiliation: Department of Clinical Hematology, Department of Pediatrics, Royal Children's Hospital, University of Melbourne, Parkville, Victoria, Australia. Electronic address: Paul.Monagle@rch.org.au.
authors.forename: Paul
authors.initials: P
authors.lastname: Monagle
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D015931:Intensive Care, Neonatal / Q000379:methods*; D012307:Risk Factors; D013923:Thromboembolism / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents
keywords: Anticoagulation; Preterm infants; Thromboembolism